APO Research
Talk to an analyst

APO RESEARCH · REPORT

Celecoxib

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Selected research

Market Structure

Global Celecoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025180 pages

Choose your research edition.

Industry ResearchCelecoxib Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Celecoxib Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Celecoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Celecoxib Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Celecoxib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Data show that more than 400 million people worldwide are currently affected by joint diseases.

Read the full market overview

The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.

The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

At present, the burden of chronic diseases will increase by 40% due to the aging of the population.

As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.

Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.

At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.

At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.

It accounted for 63.39% of the global market in 2019.

As of 2019, China relies entirely on Pfizer for celecoxib imports.

Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

This report provides an overview of the global Celecoxib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Celecoxib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Celecoxib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Celecoxib market size, projected growth trends, production technologies, key applications, and end-use industries.

Celecoxib Segment by Company

Pfizer Inc

Teva

Mylan

Apotex

Lupin

Hengrui Medicine

Celecoxib Segment by Type

50mg

100mg

200mg

400mg

Celecoxib Segment by Application

Rheumatoid arthritis

osteoarthritis

Acute pain

Musculoskeletal pain

Other diseases

Celecoxib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celecoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Celecoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celecoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Celecoxib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Celecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Celecoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Celecoxib Industry Trends Table 2. Celecoxib Industry Drivers Table 3. Celecoxib Industry Opportunities and Challenges Table 4. Celecoxib Industry Restraints Table 5. Global Celecoxib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Celecoxib Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Celecoxib Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Celecoxib Sales Market Share by Manufacturers Table 9. Global Celecoxib Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Celecoxib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Celecoxib Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Celecoxib Manufacturers, Product Type & Application Table 13. Global Celecoxib Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Celecoxib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50mg Table 17. Major Manufacturers of 100mg Table 18. Major Manufacturers of 200mg Table 19. Major Manufacturers of 400mg Table 20. Global Celecoxib Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Celecoxib Sales by Type (2021-2026) & (K Units) Table 22. Global Celecoxib Sales by Type (2027-2032) & (K Units) Table 23. Global Celecoxib Sales Market Share by Type (2021-2026) Table 24. Global Celecoxib Sales Market Share by Type (2027-2032) Table 25. Global Celecoxib Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Celecoxib Revenue by Type (2021-2026) & (K Units) Table 27. Global Celecoxib Revenue by Type (2027-2032) & (K Units) Table 28. Global Celecoxib Revenue Market Share by Type (2021-2026) Table 29. Global Celecoxib Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Rheumatoid arthritis Table 31. Major Manufacturers of osteoarthritis Table 32. Major Manufacturers of Acute pain Table 33. Major Manufacturers of Musculoskeletal pain Table 34. Major Manufacturers of Other diseases Table 35. Global Celecoxib Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Celecoxib Sales by Application (2021-2026) & (K Units) Table 37. Global Celecoxib Sales by Application (2027-2032) & (K Units) Table 38. Global Celecoxib Sales Market Share by Application (2021-2026) Table 39. Global Celecoxib Sales Market Share by Application (2027-2032) Table 40. Global Celecoxib Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Celecoxib Revenue by Application (2021-2026) & (K Units) Table 42. Global Celecoxib Revenue by Application (2027-2032) & (K Units) Table 43. Global Celecoxib Revenue Market Share by Application (2021-2026) Table 44. Global Celecoxib Revenue Market Share by Application (2027-2032) Table 45. Global Celecoxib Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Celecoxib Sales by Region (2021-2026) & (K Units) Table 47. Global Celecoxib Sales Market Share by Region (2021-2026) Table 48. Global Celecoxib Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Celecoxib Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Celecoxib Sales by Country (2021-2026) & (K Units) Table 52. North America Celecoxib Sales by Country (2027-2032) & (K Units) Table 53. Europe Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Celecoxib Sales by Country (2021-2026) & (K Units) Table 55. Europe Celecoxib Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Celecoxib Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Celecoxib Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Celecoxib Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Celecoxib Sales by Country (2027-2032) & (K Units) Table 62. Global Celecoxib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Celecoxib Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Celecoxib Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Celecoxib Revenue Market Share by Region (2021-2026) Table 66. Global Celecoxib Revenue Market Share by Region (2027-2032) Table 67. Pfizer Inc Company Information Table 68. Pfizer Inc Business Overview Table 69. Pfizer Inc Celecoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Pfizer Inc Celecoxib Product Portfolio Table 71. Pfizer Inc Recent Development Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Celecoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Teva Celecoxib Product Portfolio Table 76. Teva Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Celecoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Mylan Celecoxib Product Portfolio Table 81. Mylan Recent Development Table 82. Apotex Company Information Table 83. Apotex Business Overview Table 84. Apotex Celecoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Apotex Celecoxib Product Portfolio Table 86. Apotex Recent Development Table 87. Lupin Company Information Table 88. Lupin Business Overview Table 89. Lupin Celecoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Lupin Celecoxib Product Portfolio Table 91. Lupin Recent Development Table 92. Hengrui Medicine Company Information Table 93. Hengrui Medicine Business Overview Table 94. Hengrui Medicine Celecoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Hengrui Medicine Celecoxib Product Portfolio Table 96. Hengrui Medicine Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Celecoxib Distributors List Table 100. Celecoxib Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Celecoxib Product Image Figure 2. Global Celecoxib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Celecoxib Market Size (2021-2032) & (US$ Million) Figure 4. Global Celecoxib Sales (2021-2032) & (K Units) Figure 5. Global Celecoxib Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Celecoxib Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50mg Image Figure 9. 100mg Image Figure 10. 200mg Image Figure 11. 400mg Image Figure 12. Global Celecoxib Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Celecoxib Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Celecoxib Sales Market Share by Type (2021-2032) Figure 15. Global Celecoxib Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Celecoxib Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Celecoxib Revenue Market Share by Type (2021-2032) Figure 18. Rheumatoid arthritis Image Figure 19. osteoarthritis Image Figure 20. Acute pain Image Figure 21. Musculoskeletal pain Image Figure 22. Other diseases Image Figure 23. Global Celecoxib Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Celecoxib Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Celecoxib Sales Market Share by Application (2021-2032) Figure 26. Global Celecoxib Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Celecoxib Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Celecoxib Revenue Market Share by Application (2021-2032) Figure 29. North America Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Celecoxib Sales Market Share by Country (2021-2032) Figure 31. U.S. Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Celecoxib Sales Market Share by Country (2021-2032) Figure 36. Germany Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Celecoxib Sales Market Share by Country (2021-2032) Figure 43. China Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Celecoxib Sales Market Share by Country (2021-2032) Figure 51. Brazil Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Celecoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Celecoxib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Celecoxib Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Celecoxib Revenue (2021-2032) & (US$ Million) Figure 62. North America Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Celecoxib Revenue (2021-2032) & (US$ Million) Figure 64. Europe Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Celecoxib Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Celecoxib Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Celecoxib Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Celecoxib Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
  • 200mg
  • 400mg
Applications
  • Rheumatoid arthritis
  • osteoarthritis
  • Acute pain
  • Musculoskeletal pain
  • Other diseases
Companies covered
  • Pfizer Inc
  • Teva
  • Mylan
  • Apotex
  • Lupin
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Celecoxib Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Celecoxib Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Celecoxib Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Celecoxib Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Celecoxib Market Dynamics
  1. 2.1 Celecoxib Industry Trends
  2. 2.2 Celecoxib Industry Drivers
  3. 2.3 Celecoxib Industry Opportunities and Challenges
  4. 2.4 Celecoxib Industry Restraints
3 Celecoxib Market by Manufacturers
  1. 3.1 Global Celecoxib Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Celecoxib Sales by Manufacturers (2021-2026)
  3. 3.3 Global Celecoxib Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Celecoxib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Celecoxib Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Celecoxib Manufacturers, Product Type & Application
  7. 3.7 Global Celecoxib Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Celecoxib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Celecoxib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Celecoxib Tier 1, Tier 2, and Tier 3
4 Celecoxib Market by Type
  1. 4.1 Celecoxib Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 100mg
  4. 4.1.3 200mg
  5. 4.1.4 400mg
  6. 4.2 Global Celecoxib Sales by Type
  7. 4.2.1 Global Celecoxib Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Celecoxib Sales by Type (2021-2032)
  9. 4.2.3 Global Celecoxib Sales Market Share by Type (2021-2032)
  10. 4.3 Global Celecoxib Revenue by Type
  11. 4.3.1 Global Celecoxib Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Celecoxib Revenue by Type (2021-2032)
  13. 4.3.3 Global Celecoxib Revenue Market Share by Type (2021-2032)
5 Celecoxib Market by Application
  1. 5.1 Celecoxib Application Introduction
  2. 5.1.1 Rheumatoid arthritis
  3. 5.1.2 osteoarthritis
  4. 5.1.3 Acute pain
  5. 5.1.4 Musculoskeletal pain
  6. 5.1.5 Other diseases
  7. 5.2 Global Celecoxib Sales by Application
  8. 5.2.1 Global Celecoxib Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Celecoxib Sales by Application (2021-2032)
  10. 5.2.3 Global Celecoxib Sales Market Share by Application (2021-2032)
  11. 5.3 Global Celecoxib Revenue by Application
  12. 5.3.1 Global Celecoxib Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Celecoxib Revenue by Application (2021-2032)
  14. 5.3.3 Global Celecoxib Revenue Market Share by Application (2021-2032)
6 Global Celecoxib Sales by Region
  1. 6.1 Global Celecoxib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Celecoxib Sales by Region (2021-2032)
  3. 6.2.1 Global Celecoxib Sales by Region (2021-2026)
  4. 6.2.2 Global Celecoxib Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Celecoxib Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Celecoxib Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Celecoxib Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Celecoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Celecoxib Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Celecoxib Revenue by Region
  1. 7.1 Global Celecoxib Revenue by Region
  2. 7.1.1 Global Celecoxib Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Celecoxib Revenue by Region (2021-2026)
  4. 7.1.3 Global Celecoxib Revenue by Region (2027-2032)
  5. 7.1.4 Global Celecoxib Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Celecoxib Revenue (2021-2032)
  8. 7.2.2 North America Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Celecoxib Revenue (2021-2032)
  11. 7.3.2 Europe Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Celecoxib Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Celecoxib Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Celecoxib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer Inc
  2. 8.1.1 Pfizer Inc Company Information
  3. 8.1.2 Pfizer Inc Business Overview
  4. 8.1.3 Pfizer Inc Celecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Inc Celecoxib Product Portfolio
  6. 8.1.5 Pfizer Inc Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Celecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Celecoxib Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Celecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Celecoxib Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Apotex
  20. 8.4.1 Apotex Company Information
  21. 8.4.2 Apotex Business Overview
  22. 8.4.3 Apotex Celecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Apotex Celecoxib Product Portfolio
  24. 8.4.5 Apotex Recent Developments
  25. 8.5 Lupin
  26. 8.5.1 Lupin Company Information
  27. 8.5.2 Lupin Business Overview
  28. 8.5.3 Lupin Celecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lupin Celecoxib Product Portfolio
  30. 8.5.5 Lupin Recent Developments
  31. 8.6 Hengrui Medicine
  32. 8.6.1 Hengrui Medicine Company Information
  33. 8.6.2 Hengrui Medicine Business Overview
  34. 8.6.3 Hengrui Medicine Celecoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medicine Celecoxib Product Portfolio
  36. 8.6.5 Hengrui Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Celecoxib Value Chain Analysis
  2. 9.1.1 Celecoxib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Celecoxib Production Mode & Process
  6. 9.2 Celecoxib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Celecoxib Distributors
  9. 9.2.3 Celecoxib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst